BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA

    MDR report key: 7978621 · Received October 17, 2018

    Report

    Report Number
    MW5080621
    Event Type
    Death
    Date Received
    October 17, 2018
    Date of Event
    September 24, 2018
    Report Date
    October 16, 2018
    Manufacturer
    FERRING PHARMACEUTICALS
    Product Code
    MOZ
    UDI-DI
    55566410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    003

    Narratives

    Description of Event or Problem · 1

    PT IS DECEASED. DOSE OR AMOUNT: 20 MG MILLIGRAM(S); WEEKLY FOR 3 WEEKS, INTRA-ARTICULAR. THERAPY START DATE: (B)(6) 2014; THERAPY END DATE: (B)(6) 2018. REASON FOR USE: UNILATERAL PRIMARY OSTEOARTHRITIS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    816799 EUFLEXXA ACID, HYALURONIC INTRAARTICULAR MOZ FERRING PHARMACEUTICALS N16434A 55566410001

    Patients

    Seq Age Sex Outcome Treatment
    1 83 YR Death